Bacterial TherapeuticsBacterial Therapeutics. A review of current scientific research, applications and resources.
Edited by: Matthias Ullrich"relevant to applications in medicine, the food industry and renewable energy production" (SciTech Book News) read more ...
Experienced and authoritative experts review the most important innovations and their biotechnological applications. An interdisciplinary view that examines the area from molecular biology, genome-, transcriptome- and proteome-wide perspectives, and looks at the ecological aspects and systems biology approaches.
Bacterial TherapeuticsAdapted from Parks et al. in Probiotics and Prebiotics: Scientific Aspects
Bacterial Therapeutics: The microbiota of the healthy human vagina is dominated by Lactobacillus species, which play an important role in protecting the host from urogenital infections. Disruption of the Lactobacillus-dominated microbiota can lead to abnormal vaginal microbial communities associated with bacterial vaginosis, and an increased incidence of urinary tract infection (UTI). In addition, epidemiological studies suggest that the normal vaginal microbial ecosystem may play a critical role in reducing the risk of sexually transmitted infections, including human immunodeficiency virus type 1 (HIV-1). Chapter 8 of Probiotics and Prebiotics: Scientific Aspects focuses on the role of lactobacilli in the vaginal ecosystem and the rational use of these bacteria as therapeutic agents for the treatment and prevention of urogenital infections.
- Metagenomics of the Microbial Nitrogen Cycle
- Pathogenic Neisseria
- Human Pathogenic Fungi
- Applied RNAi
- Molecular Diagnostics
- Phage Therapy
- Bioinformatics and Data Analysis in Microbiology
- The Cell Biology of Cyanobacteria
- Pathogenic Escherichia coli
- Campylobacter Ecology and Evolution